Published in Hum Pathol on August 01, 1987
Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut (1996) 2.79
Microscopic colitis syndrome. Gut (1995) 1.98
Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut (1992) 1.70
Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut (1995) 1.64
Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut (2003) 1.47
Metachronous occurrence of collagenous colitis and ulcerative colitis. Gut (1991) 1.31
Interchange between collagenous and lymphocytic colitis in severe disease with autoimmune associations requiring colectomy: a case report. Gut (1996) 1.30
Distribution of collagenous colitis: utility of flexible sigmoidoscopy. Gut (1992) 1.23
Collagenous colitis: jejunal and colorectal pathology. J Clin Pathol (1992) 1.12
Vascular endothelial growth factor (VEGF)--a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci (2004) 1.02
Autoantibodies and immunoglobulins in collagenous colitis. Gut (1996) 0.99
Fibrogenesis and fibrolysis in collagenous colitis. Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression. Am J Pathol (1999) 0.94
Evolution of collagenous colitis into severe and extensive ulcerative colitis. Can J Gastroenterol (2007) 0.94
Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis (2004) 0.93
Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013. ISRN Gastroenterol (2013) 0.92
The differential diagnosis of idiopathic inflammatory disease by colorectal biopsy. Int J Colorectal Dis (1987) 0.91
Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis. Dig Dis Sci (2001) 0.85
Microscopic colitis. World J Gastroenterol (2012) 0.81
Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis. Clin Colon Rectal Surg (2007) 0.80
Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients. World J Gastroenterol (2006) 0.80
A unique case of collagenous colitis presenting as protein-losing enteropathy successfully treated with prednisolone. World J Gastroenterol (2008) 0.79
Enhanced levels of chemokines and their receptors in the colon of microscopic colitis patients indicate mixed immune cell recruitment. Mediators Inflamm (2015) 0.79
Diagnosis and management of microscopic colitis. Can Fam Physician (2003) 0.78
Collagenous colitis: response to treatment. Postgrad Med J (1988) 0.75
Cytokine expression of microscopic colitis including interleukin-17. Gut Liver (2015) 0.75
Optimal management of collagenous colitis: a review. Clin Exp Gastroenterol (2016) 0.75
Subepithelial basement membrane thickness in patients with normal colonic mucosal appearance in colonoscopy: results from southern Turkey. World J Gastroenterol (2004) 0.75
New insights and challenges in microscopic colitis. Therap Adv Gastroenterol (2015) 0.75
Enteropathic arthritis in association with collagenous colitis. Clin Rheumatol (1998) 0.75
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 8.34
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (1987) 7.12
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun (1985) 6.57
Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (1991) 6.15
Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology (1976) 6.15
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68
Allelotype of colorectal carcinomas. Science (1989) 5.54
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol (1994) 4.43
Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res (1987) 4.25
Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology (1995) 4.24
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Grading and classification of chronic gastritis: one American response to the Sydney system. Gastroenterology (1992) 3.99
Clonal analysis of human colorectal tumors. Science (1987) 3.72
Hypomethylation of DNA from benign and malignant human colon neoplasms. Science (1985) 3.72
Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
Preliminary evidence for genetic anticipation in Crohn's disease. Lancet (1996) 3.32
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res (1995) 3.13
Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res (1997) 3.09
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol (1989) 3.02
Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology (1982) 2.95
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med (1998) 2.91
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Intestinal ulceration--a complication of celiac disease. N Engl J Med (1967) 2.90
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
Collagenous colitis with mucosal tears on endoscopic insufflation: a unique presentation. Gut (2002) 2.81
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol (1997) 2.57
Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology (1991) 2.55
Mad-related genes in the human. Nat Genet (1996) 2.51
Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology (1996) 2.50
Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science (1985) 2.49
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol (1987) 2.31
Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol (2001) 2.30
Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA (1989) 2.29
AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med (1991) 2.13
Small bowel morphology in experimental canine cholera. A light and electron microscopic study. Lab Invest (1970) 2.12
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet (2004) 2.10
Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology (1984) 2.08
Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery (1987) 2.07
High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci U S A (1991) 2.07
Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther (2014) 2.04
Cryptosporidiosis in an immunosuppressed renal-transplant recipient with IgA deficiency. Am J Clin Pathol (1979) 2.03
Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology (1992) 1.98
Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst (1993) 1.94
Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol (1997) 1.93
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut (1996) 1.89
CpG island methylation in colorectal adenomas. Am J Pathol (2001) 1.88
Gastroduodenal Crohn's disease: the focus is on focality. Gastroenterology (1997) 1.86
Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology (2000) 1.86
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology (1995) 1.86